<DOC>
	<DOC>NCT00902993</DOC>
	<brief_summary>This study is designed to evaluate the safety, tolerability and PK of AZD1446 in Subjects when given as multiple dose administration for either 7 Days (Day 1 single dose, Day 2-6 multiple doses) in Part A and optionally at fractionated doses for 1 Day in Part B.</brief_summary>
	<brief_title>Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446</brief_title>
	<detailed_description />
	<criteria>Male or nonfertile female, young or elderly Subjects, aged ≥18 to ≤50 or ≥65 to ≤80 Body mass index (BMI) between 19 and 30 kg/m2 Clinically normal findings on physical examination History of any clinically significant disease or disorder History of severe allergy/hypersensitivity reactions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>MAD</keyword>
	<keyword>NNR</keyword>
	<keyword>to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects</keyword>
	<keyword>AZD1446</keyword>
</DOC>